• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量筛选和量子力学在鉴定针对 SARS-CoV-2 Nsp3 的 Mac1 结构域的有效抑制剂中的应用。

High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.

出版信息

IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1262-1270. doi: 10.1109/TCBB.2020.3037136. Epub 2021 Aug 6.

DOI:10.1109/TCBB.2020.3037136
PMID:33306471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8769010/
Abstract

SARS-CoV-2 encodes the Mac1 domain within the large nonstructural protein 3 (Nsp3), which has an ADP-ribosylhydrolase activity conserved in other coronaviruses. The enzymatic activity of Mac1 makes it an essential virulence factor for the pathogenicity of coronavirus (CoV). They have a regulatory role in counteracting host-mediated antiviral ADP-ribosylation, which is unique part of host response towards viral infections. Mac1 shows highly conserved residues in the binding pocket for the mono and poly ADP-ribose. Therefore, SARS-CoV-2 Mac1 enzyme is considered as an ideal drug target and inhibitors developed against them can possess a broad antiviral activity against CoV. ADP-ribose-1 phosphate bound closed form of Mac1 domain is considered for screening with large database of ZINC. XP docking and QPLD provides strong potential lead compounds, that perfectly fits inside the binding pocket. Quantum mechanical studies expose that, substrate and leads have similar electron donor ability in the head regions, that allocates tight binding inside the substrate-binding pocket. Molecular dynamics study confirms the substrate and new lead molecules presence of electron donor and acceptor makes the interactions tight inside the binding pocket. Overall binding phenomenon shows both substrate and lead molecules are well-adopt to bind with similar binding mode inside the closed form of Mac1.

摘要

SARS-CoV-2 在其大型非结构蛋白 3(Nsp3)中编码 Mac1 结构域,该结构域在其他冠状病毒中具有保守的 ADP-核糖基水解酶活性。Mac1 的酶活性使其成为冠状病毒(CoV)致病性的必需毒力因子。它们在拮抗宿主介导的抗病毒 ADP-核糖基化方面具有调节作用,这是宿主对病毒感染的独特反应的一部分。Mac1 在结合口袋中显示出对单和多 ADP-核糖基的高度保守残基。因此,SARS-CoV-2 Mac1 酶被认为是一个理想的药物靶点,针对它们开发的抑制剂可以对 CoV 具有广泛的抗病毒活性。ADP-核糖-1 磷酸结合的 Mac1 结构域封闭形式被认为可用于 ZINC 大型数据库的筛选。XP 对接和 QPLD 提供了强有力的潜在先导化合物,它们完美地适合于结合口袋内。量子力学研究表明,在头部区域,底物和先导具有相似的电子供体能力,这在底物结合口袋内分配了紧密的结合。分子动力学研究证实,底物和新的先导分子具有电子供体和受体,使得在结合口袋内的相互作用紧密。整体结合现象表明,底物和先导分子都以相似的结合模式很好地适应于封闭形式的 Mac1 结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/a4328fca2c19/singh5-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/bac5dadcc2a0/singh1-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/1469ea43b023/singh2-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/4bdfbee7eac8/singh3-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/2934d3ffc60f/singh4-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/a4328fca2c19/singh5-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/bac5dadcc2a0/singh1-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/1469ea43b023/singh2-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/4bdfbee7eac8/singh3-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/2934d3ffc60f/singh4-3037136.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/8769010/a4328fca2c19/singh5-3037136.jpg

相似文献

1
High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.高通量筛选和量子力学在鉴定针对 SARS-CoV-2 Nsp3 的 Mac1 结构域的有效抑制剂中的应用。
IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1262-1270. doi: 10.1109/TCBB.2020.3037136. Epub 2021 Aug 6.
2
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.SARS-CoV-2 保守宏结构域是一种单 ADP-核糖基水解酶。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01969-20.
3
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.高通量筛选发现抑制 SARS-CoV-2 Mac1-ADP-ribose 结合的化合物。
Antiviral Res. 2022 Jul;203:105344. doi: 10.1016/j.antiviral.2022.105344. Epub 2022 May 19.
4
Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3.发现 SARS-CoV-2 Nsp3 的 Mac1 结构域的类药物配体。
SLAS Discov. 2020 Dec;25(10):1162-1170. doi: 10.1177/2472555220960428. Epub 2020 Sep 28.
5
Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.利用人聚(ADP-核糖)糖苷水解酶(PARG)结构及抑制剂的见解靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白3(Nsp3)宏结构域。
Prog Biophys Mol Biol. 2021 Aug;163:171-186. doi: 10.1016/j.pbiomolbio.2021.02.002. Epub 2021 Feb 23.
6
-based screening of natural products as potential inhibitors of SARS-CoV-2 macrodomain 1.基于天然产物的 SARS-CoV-2 宏结构域 1 抑制剂筛选
J Biomol Struct Dyn. 2024 Jul;42(10):5229-5237. doi: 10.1080/07391102.2023.2226745. Epub 2023 Jun 22.
7
Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3.SARS-CoV-2 nsp3 的 Mac1 结构域与 ADP-核糖结合的分子基础。
Biochemistry. 2020 Jul 21;59(28):2608-2615. doi: 10.1021/acs.biochem.0c00309. Epub 2020 Jul 6.
8
The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)保守的大分子结构域是一种单磷酸腺苷核糖水解酶。
bioRxiv. 2020 Oct 28:2020.05.11.089375. doi: 10.1101/2020.05.11.089375.
9
Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.设计、合成与评估 SARS-CoV-2 nsp3 结构域大分子抑制剂。
Bioorg Med Chem. 2022 Aug 1;67:116788. doi: 10.1016/j.bmc.2022.116788. Epub 2022 May 11.
10
Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.鉴定 FDA 批准的药物和核苷类似物作为新型冠状病毒 A1pp 结构域抑制剂的研究:一项计算机模拟研究。
Comput Biol Med. 2021 Mar;130:104185. doi: 10.1016/j.compbiomed.2020.104185. Epub 2020 Dec 19.

引用本文的文献

1
Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors.基于结构的高通量虚拟筛选和分子动力学模拟发现新型 SARS-CoV-2 NSP3 Mac1 结构域抑制剂。
Viruses. 2023 Nov 22;15(12):2291. doi: 10.3390/v15122291.
2
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)巨噬细胞1(Mac1)抑制剂的现状更新
Pathogens. 2023 Oct 7;12(10):1221. doi: 10.3390/pathogens12101221.
3
Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target.

本文引用的文献

1
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2 或 n-COVID-19)的蛋白,引发 COVID-19。
Protein J. 2020 Jun;39(3):198-216. doi: 10.1007/s10930-020-09901-4.
2
The SARS-CoV-2 outbreak from a one health perspective.从“同一健康”视角看严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情
One Health. 2020 Dec;10:100127. doi: 10.1016/j.onehlt.2020.100127. Epub 2020 Mar 16.
3
The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
鉴定 SARS-CoV-2 的 SARS 特有结构域作为抗病毒靶点。
Nat Commun. 2023 Jul 6;14(1):3999. doi: 10.1038/s41467-023-39709-6.
4
Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma.基于结构的虚拟筛选、EGFR 的分子对接、分子动力学模拟在胶质母细胞瘤临床治疗中的应用。
Appl Biochem Biotechnol. 2023 Aug;195(8):5094-5119. doi: 10.1007/s12010-023-04430-z. Epub 2023 Mar 28.
5
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses.保守的大分子结构域是冠状病毒和甲病毒的潜在治疗靶点。
Pathogens. 2022 Jan 14;11(1):94. doi: 10.3390/pathogens11010094.
6
Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.人工智能和机器学习方法在药物设计中的应用:制药行业的挑战与机遇。
Mol Divers. 2022 Jun;26(3):1893-1913. doi: 10.1007/s11030-021-10326-z. Epub 2021 Oct 23.
7
An overview of potential inhibitors targeting non-structural proteins 3 (PL and Mac1) and 5 (3CL/M) of SARS-CoV-2.靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白3(PL和Mac1)和5(3CL/M)的潜在抑制剂概述。
Comput Struct Biotechnol J. 2021;19:4868-4883. doi: 10.1016/j.csbj.2021.08.036. Epub 2021 Aug 24.
8
Interrogation of SrtA active site loop forming open/close lid conformations through extensive MD simulations for understanding binding selectivity of SrtA inhibitors.通过广泛的分子动力学模拟探究Sortase A(SrtA)活性位点环形成开放/关闭盖子构象,以了解SrtA抑制剂的结合选择性。
Saudi J Biol Sci. 2021 Jul;28(7):3650-3659. doi: 10.1016/j.sjbs.2021.05.009. Epub 2021 May 8.
9
Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from .严重急性呼吸综合征冠状病毒2开放状态包膜蛋白的结构见解以及来自阿育吠陀药用植物的活性植物化学物质对其的抑制作用
Saudi J Biol Sci. 2021 Jun;28(6):3594-3601. doi: 10.1016/j.sjbs.2021.03.036. Epub 2021 Mar 18.
10
Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.微秒级分子动力学模拟和多构象虚拟筛选以鉴定针对新型冠状病毒主要蛋白酶的潜在抗COVID-19抑制剂
Front Chem. 2021 Jan 13;8:595273. doi: 10.3389/fchem.2020.595273. eCollection 2020.
病毒宏结构域对抗宿主抗病毒 ADP-核糖基化。
Viruses. 2020 Mar 31;12(4):384. doi: 10.3390/v12040384.
4
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
5
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
6
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.中国新型冠状病毒(2019-nCoV)的基因组组成和分化。
Cell Host Microbe. 2020 Mar 11;27(3):325-328. doi: 10.1016/j.chom.2020.02.001. Epub 2020 Feb 7.
7
Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through approaches.通过 方法研究黄酮类化合物靶向 Zika 病毒 NS2B-NS3 蛋白酶的分子相互作用。
J Biomol Struct Dyn. 2021 Jan;39(1):272-284. doi: 10.1080/07391102.2019.1709546. Epub 2020 Jan 10.
8
Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).结合计算机模拟和体外方法鉴定有效的磷脂酶 A2(PLA2)抑制剂。
Int J Biol Macromol. 2020 Feb 1;144:53-66. doi: 10.1016/j.ijbiomac.2019.12.091. Epub 2019 Dec 12.
9
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections.病毒先天性免疫逃逸与新出现的RNA病毒感染的发病机制
Viruses. 2019 Oct 18;11(10):961. doi: 10.3390/v11100961.
10
Innate Immune Evasion by Human Respiratory RNA Viruses.人体呼吸 RNA 病毒的先天免疫逃避。
J Innate Immun. 2020;12(1):4-20. doi: 10.1159/000503030. Epub 2019 Oct 14.